Download Litt's Drug Eruptions & Reactions Manual, 17th Edition by Jerome Z. Litt, Neil Shear PDF

By Jerome Z. Litt, Neil Shear

Litt’s Drug Eruptions and Reactions guide (D.E.R.M.), is a advisor to drug eruptions, adversarial reactions and clinically suitable drug–drug interactions linked to over 1300 medicines. this straightforward, well-organised ebook systematically catalogues hostile reactions and cutaneous side-effects of gear which are used to regard dozens of conditions.
Internationally trusted for almost 2 a long time by means of dermatologists and clinical practitioners, the ebook includes designated profiles for medications which are indexed and listed in alphabetical order. The ebook holds finished drug info and gives an unprecedented concentrate on cutaneous and mucosal response patterns.
Over 35,000 hostile reactions and drug eruptions are indexed, and anywhere attainable, occurrence degrees for reactions are integrated. response listings and occurrence information are supported through hundreds of thousands of up to date, peer-reviewed references from MEDLINE, together with drug trials, assessment articles and case experiences.
Also within the seventeenth variation:
• being pregnant type details for over one thousand medicinal drugs, integrated for the 1st time
• vitamins, vaccines and different biologics additionally profiled
• Over 60 new drug profiles added

Show description

Read or Download Litt's Drug Eruptions & Reactions Manual, 17th Edition PDF

Similar dermatology books

Skin Immune System: Cutaneous Immunology and Clinical Immunodermatology, Third Edition

Best clinical authors give a contribution their services and placed a wealth of advanced details into point of view in epidermis Immune process: Cutaneous Immunology & medical Immunodermatology, 3rd version. This version presents an summary of the outside immune method (SIS), a unconditionally up to date part on immunodermatological illnesses, and 6 new chapters.

Sepsis (Competency-Based Critical Care)

Notice new, potent concepts to avoid and deal with sepsis. during this booklet, prime medical examiners contemplate how the pathways implicated in early and past due sepsis engage. subsequent, the e-book describes various pharmacological ways that assist you to offer state-of-the-technology deal with sufferers in either early and overdue sepsis.

Dermatology Secrets Plus

Dermatology secrets and techniques Plus, 4th variation, by means of Drs. James E. Fitzpatrick and Joseph G. Morelli, delivers the dermatology solutions you must be triumphant in your rotations and forums - PLUS even more. Now in shiny colour all through, this in charge evaluation and reference keeps its enticing question-and-answer layout, perfect for board coaching, recertification tests, or speedy scientific reference.

Immunology of the Skin: Basic and Clinical Sciences in Skin Immune Responses

This ebook stories the position of every mobilephone subset within the dermis, supplying the fundamentals for knowing pores and skin immunology and the mechanisms of dermis ailments. the outside is likely one of the immune organs and is constantly uncovered to international antigens and exterior stimuli that has to be monitored and characterised for attainable removing.

Extra resources for Litt's Drug Eruptions & Reactions Manual, 17th Edition

Example text

Only licensed for use in female patients. 4%) Sedation Flushing (>10%) Hypotension (2009): Sung CW+, Can J Cardiol 25(10), e359 Myocardial infarction (2009): Sung CW+, Can J Cardiol 25(10), e359 Thrombophlebitis (1994): Cassano GB+, Eur Neuropsychopharmacol 4(1), 47 Seizures (2002): Mena Martin FJ+, Med Clin (Barc) 119(20), 797 (withdrawal) Slurred speech (1994): Cassano GB+, Eur Neuropsychopharmacol 4(1), 47 Neuromuscular/Skeletal Asthenia (2002): Barthelmes L+, Int J Impot Res 14(3), 199 [REVIEW] Central Nervous System Hyperesthesia (<1%) Gastrointestinal/Hepatic Gastric obstruction (2007): Lacher M+, Eur J Pediatr Surg 17(5), 362 (in neonate) (2006): Glue P+, Am J Ther 13(5), 418 (1994): Cassano GB+, Eur Neuropsychopharmacol 4(1), 47 Ataxia (1994): Cassano GB+, Eur Neuropsychopharmacol 4(1), 47 Endocrine/Metabolic Galactorrhea Gynecomastia Otic Tinnitus Other Allergic reactions Death Vomiting (2007): Lacher M+, Eur J Pediatr Surg 17(5), 362 Genitourinary Balanitis (<1%) Priapism (4%) [5] (1999): Lue TF, J Urol 161, 725 (1998): Bettocchi C+, Br J Urol 81, 926 Local Application-site burning (2006): Kielbasa LA+, Ann Pharmacother 40(7-8), 1369 [REVIEW] Application-site pruritus (2006): Kielbasa LA+, Ann Pharmacother 40(7-8), 1369 [REVIEW] Injection-site ecchymoses (1–10%) (2005): Wolf BC+, J Forensic Sci 50(1), 192 (with oxycodone) (1996): Linet OI+, N Engl J Med 334, 873 (8%) Injection-site hematoma (3%) Injection-site inflammation (<1%) Injection-site pain (2%) ALPROSTADIL (1996): Hellstrom WJG, Urology 48, 851 Synonyms: PGE; prostaglandin E1 Trade names: Caverject (Pfizer), Edex (Schwarz), Lyple, Minprog, Muse (Vivus), Palux, Prostin VR (Pfizer), Prostine VR, Prostivas Indications: Impotence, to maintain patent ductus arteriosus Class: Prostaglandin Half-life: 5–10 minutes Clinically important, potentially hazardous interactions with: none known Pregnancy category: D Note: Alprostadil is not indicated for use in women.

Com Hyperhidrosis (2010): van der Ploeg AT+, N Engl J Med 362(15), 1396 Hypersensitivity Livedo reticularis Pallor Pruritus Rash (54%) Urticaria (21%) Neuromuscular/Skeletal Asthenia (2008): Cheng JW, Clin Ther 30(1), 31 Gastrointestinal/Hepatic Abdominal pain Respiratory Cough (2010): van der Ploeg AT+, N Engl J Med 362(15), 1396 (5–8%) (2006): Vaidyanathan S+, Int J Clin Pract 60(11), 1343 Ocular Periorbital edema Mucosal Oral candidiasis (31%) Cardiovascular Bradycardia (21%) Flushing (21%) ALITRETINOIN (2010): van der Ploeg AT+, N Engl J Med 362(15), 1396 (5–8%) Hypertension (5–8%) (2010): van der Ploeg AT+, N Engl J Med 362(15), 1396 (5–8%) Tachycardia (23%) Central Nervous System Fever (97%) Headache Neuromuscular/Skeletal Asthenia Gastrointestinal/Hepatic Vomiting (5–8) (2010): van der Ploeg AT+, N Engl J Med 362(15), 1396 Trade name: Panretin (Ligand) Indications: Kaposi’s sarcoma cutaneous lesions Class: Retinoid Half-life: N/A Clinically important, potentially hazardous interactions with: none known Pregnancy category: D Skin Abrasion Bullous dermatitis Burning (2002): Morganroth GS, Arch Dermatol 138, 542 Respiratory Cough (46%) Pneumonia (46%) Rhinitis Upper respiratory infection (44%) Otic Otitis (44%) Ocular Periorbital edema Local Application-site reactions (51%) Edema (3–8%) (2000): Duvic M+, Arch Dermatol 136, 1461 (3%) Exfoliative dermatitis (3–9%) Photosensitivity Pigmentation (3%) (2000): Duvic M+, Arch Dermatol 136, 1461 (3%) Pruritus (8–11%) Rash (25–77%) (2000): Duvic M+, Arch Dermatol 136, 1461 (69%) Toxicity (2002): Miles SA+, AIDS 16(3), 421 Ulcerations (2%) (2000): Duvic M+, Arch Dermatol 136, 1461 Xerosis (10%) ALISKIREN (2000): Duvic M+, Arch Dermatol 136, 1461 (10%) Trade names: Tekamlo (Novartis), Tekturna (Novartis) Indications: Hypertension Class: Antihypertensive, Renin inhibitor Half-life: 24 hours Clinically important, potentially hazardous interactions with: celecoxib, furosemide, ketoconazole Pregnancy category: D (category C in first trimester; category D in second and third trimesters) Note: Tekamlo is aliskiren and amlodipine.

Com Hyperhidrosis (2010): van der Ploeg AT+, N Engl J Med 362(15), 1396 Hypersensitivity Livedo reticularis Pallor Pruritus Rash (54%) Urticaria (21%) Neuromuscular/Skeletal Asthenia (2008): Cheng JW, Clin Ther 30(1), 31 Gastrointestinal/Hepatic Abdominal pain Respiratory Cough (2010): van der Ploeg AT+, N Engl J Med 362(15), 1396 (5–8%) (2006): Vaidyanathan S+, Int J Clin Pract 60(11), 1343 Ocular Periorbital edema Mucosal Oral candidiasis (31%) Cardiovascular Bradycardia (21%) Flushing (21%) ALITRETINOIN (2010): van der Ploeg AT+, N Engl J Med 362(15), 1396 (5–8%) Hypertension (5–8%) (2010): van der Ploeg AT+, N Engl J Med 362(15), 1396 (5–8%) Tachycardia (23%) Central Nervous System Fever (97%) Headache Neuromuscular/Skeletal Asthenia Gastrointestinal/Hepatic Vomiting (5–8) (2010): van der Ploeg AT+, N Engl J Med 362(15), 1396 Trade name: Panretin (Ligand) Indications: Kaposi’s sarcoma cutaneous lesions Class: Retinoid Half-life: N/A Clinically important, potentially hazardous interactions with: none known Pregnancy category: D Skin Abrasion Bullous dermatitis Burning (2002): Morganroth GS, Arch Dermatol 138, 542 Respiratory Cough (46%) Pneumonia (46%) Rhinitis Upper respiratory infection (44%) Otic Otitis (44%) Ocular Periorbital edema Local Application-site reactions (51%) Edema (3–8%) (2000): Duvic M+, Arch Dermatol 136, 1461 (3%) Exfoliative dermatitis (3–9%) Photosensitivity Pigmentation (3%) (2000): Duvic M+, Arch Dermatol 136, 1461 (3%) Pruritus (8–11%) Rash (25–77%) (2000): Duvic M+, Arch Dermatol 136, 1461 (69%) Toxicity (2002): Miles SA+, AIDS 16(3), 421 Ulcerations (2%) (2000): Duvic M+, Arch Dermatol 136, 1461 Xerosis (10%) ALISKIREN (2000): Duvic M+, Arch Dermatol 136, 1461 (10%) Trade names: Tekamlo (Novartis), Tekturna (Novartis) Indications: Hypertension Class: Antihypertensive, Renin inhibitor Half-life: 24 hours Clinically important, potentially hazardous interactions with: celecoxib, furosemide, ketoconazole Pregnancy category: D (category C in first trimester; category D in second and third trimesters) Note: Tekamlo is aliskiren and amlodipine.

Download PDF sample

Rated 4.40 of 5 – based on 28 votes